SCHEMBL7419926

SCHEMBL7419926

COc1ccc(S(=O)(=O)NCC(NS(=O)(=O)c2ccc(C)cc2)C(=O)NO)cc1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MMP7 P09237 3/20 0.60
MMP9 P14780 2/20 0.60
MMP10 P09238 1/20 0.60
ALDH1A1 P00352 5/20 0.59
MMP13 P45452 3/20 0.58
TSHR P16473 1/20 0.51
MEP1B Q16820 1/20 0.51
GAA P10253 1/20 0.51
MAPT P10636 1/20 0.51
BMP1 P13497 5/20 0.50
HPGD P15428 1/20 0.50
HSD17B10 Q99714 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
MMP1 P03956 1/20 0.50
MMP2 P08253 1/20 0.50
MMP8 P22894 1/20 0.50
EGFR P00533 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7417246 0.95 MMP7 (0.65) MMP7MMP9MMP10ALDH1A1MMP13
SCHEMBL8006415 0.91 MMP7 (0.70) MMP7MMP9MMP10ALDH1A1MMP13
SCHEMBL7411340 0.89 MMP7 (0.59) MMP7MMP9MMP10MMP13MEP1B
SCHEMBL7417827 0.89 MMP7 (0.59) MMP7MMP9MMP10MMP13MEP1B
SCHEMBL8390504 0.88 MMP13 (0.56) MMP7MMP9ALDH1A1MMP13GAA
SCHEMBL8018838 0.88 MMP13 (0.56) MMP7MMP9ALDH1A1MMP13GAA
SCHEMBL7423461 0.88 MMP7 (0.58) MMP7MMP9MMP10ALDH1A1MMP13
SCHEMBL7416682 0.88 MMP7 (0.58) MMP7MMP9MMP10ALDH1A1MMP13
SCHEMBL7415839 0.87 MMP7 (0.66) MMP7MMP9MMP10ALDH1A1MMP13
SCHEMBL7414877 0.87 MMP7 (0.66) MMP7MMP9MMP10ALDH1A1MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218389-B1 FOR THERAPY AND PROPHYLAXIS OF ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS; SKIN DISORDERS; OCULAR DISORDERS; INFLAMMATION AND GUM DISEASES, MULTIPLE SCLEROSIS, CACHEXIA, PREVENTING LOOSENING OF PROSTHETIC DEVICES THE PROCTER & GAMBLE CO. 2001-04-17 US disclosed
EP-1009737-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2000-06-21 EP disclosed
WO-1999006340-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1999-02-11 WO disclosed